ASHENEWS reports that renowned global biopharmaceutical company, AstraZeneca has announced plans to invest 1.5 billion dollars in building a manufacturing facility in Singapore for antibody-drug conjugates (ADCs).
Trending
- KHETFUND hands over Bargi health post project to contractor
- UNICEF urges Imo to boost maternal, child nutrition funding
- CS-SUNN urges Borno to prioritise nutrition in 2027 budget
- Africa CDC launches clinical research training programme
- FG inaugurates financial and digital monitoring system for SAPZ
- NADF receives N3.4m surplus from Jaiz Takaful
- FAAN to temporarily close Owerri airport runway for repairs
- Transport major obstacle for farmers – Ali
